Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DALNASDAQ:PPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDALDelta Air Lines$49.46+5.1%$46.22$34.74▼$69.98$32.30B1.519.68 million shs10.20 million shsPPHVanEck Pharmaceutical ETF$90.05-0.8%$86.49$77.67▼$99.51$647.46M0.72262,283 shs255,471 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDALDelta Air Lines0.00%-7.95%-7.96%+0.11%-3.68%PPHVanEck Pharmaceutical ETF0.00%+1.66%+5.44%-2.69%-0.98%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDALDelta Air Lines4.9723 of 5 stars4.55.02.50.62.11.73.8PPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDALDelta Air Lines 3.00Buy$62.0825.52% UpsidePPHVanEck Pharmaceutical ETF 2.73Moderate Buy$90.05N/ACurrent Analyst Ratings BreakdownLatest MLC, DAL, PPH, and WTB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2025DALDelta Air LinesUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetNeutral ➝ Buy$46.00 ➝ $66.005/13/2025DALDelta Air LinesSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform5/8/2025DALDelta Air LinesUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$42.00 ➝ $46.004/10/2025DALDelta Air LinesTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy$45.00 ➝ $50.004/8/2025DALDelta Air LinesBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$80.00 ➝ $58.004/7/2025DALDelta Air LinesUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$77.00 ➝ $42.004/7/2025DALDelta Air LinesSusquehannaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetPositive ➝ Positive$80.00 ➝ $50.004/3/2025DALDelta Air LinesDbs BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/3/2025DALDelta Air LinesBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$65.00 ➝ $56.004/2/2025DALDelta Air LinesThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$83.00 ➝ $60.00(Data available from 6/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDALDelta Air Lines$61.94B0.52$7.81 per share6.33$23.66 per share2.09PPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDALDelta Air Lines$3.46B$5.649.285.970.755.61%30.41%5.30%7/10/2025 (Estimated)PPHVanEck Pharmaceutical ETFN/AN/A24.60∞N/AN/AN/AN/AN/ALatest MLC, DAL, PPH, and WTB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/10/2025Q2 2025DALDelta Air Lines$1.90N/AN/AN/A$16.16 billionN/A4/9/2025Q1 2025DALDelta Air Lines$0.84$0.46-$0.38$0.37$13.85 billion$12.98 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDALDelta Air Lines$0.601.21%N/A10.64%1 YearsPPHVanEck Pharmaceutical ETF$1.701.89%N/AN/AN/ALatest MLC, DAL, PPH, and WTB DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/24/2025DALDelta Air Linesquarterly$0.151.43%5/13/20255/13/20256/3/20253/31/2025PPHVanEck Pharmaceutical ETFQuarterly$0.52452.36%4/1/20254/1/20254/4/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDALDelta Air Lines0.920.370.32PPHVanEck Pharmaceutical ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDALDelta Air Lines69.93%PPHVanEck Pharmaceutical ETFN/AInsider OwnershipCompanyInsider OwnershipDALDelta Air Lines0.88%PPHVanEck Pharmaceutical ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDALDelta Air Lines95,000652.95 million640.27 millionOptionablePPHVanEck Pharmaceutical ETF147,0007.19 millionN/AOptionableMLC, WTB, DAL, and PPH HeadlinesRecent News About These CompaniesShould You Invest in the VanEck Pharmaceutical ETF (PPH)?May 21, 2025 | zacks.comPPH, Big Pharma Stocks Volatile on Trump Drug PricingMay 14, 2025 | finance.yahoo.comETFs on the Move Post U.S.-China Trade DealMay 12, 2025 | zacks.comA Look at Pharma ETFs After Strong Q1 EarningsMay 8, 2025 | zacks.comPPH: Will Overcome Tariffs, But Competitor Funds Look StrongerApril 14, 2025 | seekingalpha.comBig Pharma higher after tariff exemption despite ongoing uncertaintiesApril 3, 2025 | msn.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?March 20, 2025 | zacks.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?January 16, 2025 | zacks.com(PPH) Investment ReportJanuary 6, 2025 | news.stocktradersdaily.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.4110December 27, 2024 | msn.comPPH Is a Pertinent Healthcare Idea for 2025December 19, 2024 | etftrends.com(PPH) Pivots Trading Plans and Risk ControlsDecember 16, 2024 | news.stocktradersdaily.comWhen the Price of (PPH) Talks, People ListenDecember 6, 2024 | news.stocktradersdaily.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?November 11, 2024 | zacks.comThe Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNROctober 17, 2024 | finance.yahoo.comDiversified Exposure To The Weight Loss Drug MarketOctober 10, 2024 | seekingalpha.comPharma Stocks Losing Ground After A Remarkable Rally, Downgrading PPHOctober 3, 2024 | seekingalpha.comHealthcare ETFs Starting to Look HealthyOctober 1, 2024 | etftrends.comAbbVie stock analysis: Rinvoq and Skyrizi are big catalystsOctober 1, 2024 | msn.comDoubleLine's Jeff Gundlach on the Fed, Gold and Private CreditSeptember 23, 2024 | etftrends.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in ValueIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsWhat Ray Dalio's Latest Moves Tell Investors By Gabriel Osorio-Mazilli | May 19, 2025View What Ray Dalio's Latest Moves Tell Investors MLC, WTB, DAL, and PPH Company DescriptionsDelta Air Lines NYSE:DAL$49.46 +2.42 (+5.14%) Closing price 03:59 PM EasternExtended Trading$48.80 -0.66 (-1.33%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo in the United States and internationally. The company operates through two segments, Airline and Refinery. Its domestic network centered on core hubs in Atlanta, Minneapolis-St. Paul, Detroit, and Salt Lake City, as well as coastal hub positions in Boston, Los Angeles, New York-LaGuardia, New York-JFK, and Seattle; and international network centered on hubs and market presence in Amsterdam, Bogota, Lima, Mexico City, London-Heathrow, Paris-Charles de Gaulle, Sao Paulo, Seoul-Incheon, and Tokyo. The company sells its tickets through various distribution channels, including delta.com and the Fly Delta app; acts as a reservations specialists; and operates online travel and traditional brick and mortar agencies. It also provides aircraft maintenance and engineering support, repair, and overhaul services; and vacation packages to third-party consumers. The company operates through a fleet of approximately 1,273 aircrafts. Delta Air Lines, Inc. was founded in 1924 and is based in Atlanta, Georgia.VanEck Pharmaceutical ETF NASDAQ:PPH$90.05 -0.73 (-0.80%) Closing price 04:00 PM EasternExtended Trading$89.91 -0.14 (-0.16%) As of 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New Catalysts to Drive NVIDIA’s Stock Price Even Higher Palantir Defies Bears, Leads S&P 500 in 2025 AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Could Meta and Eli Lilly Trigger the Next Stock Split Boom? Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker? Why Analysts Are Bullish on Celsius Stock After 30% Drop 3 Stocks With Rising Dividends Investors Shouldn’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
